53 research outputs found
Application and Safety Evaluation of Integrated TCM-WM in the Treatment of COVID-19
Introduction: With the emergence of more infectious mutant strains and the appearance of new crown sequelae, early precise treatment is particularly important. The traditional Chinese medicine and Western medicine (TCM-WM) treatment plan exhibits unique superiority in the COVID-19 treatment, but the efficacy and safety have not been fully elucidated. Methods: A analysis of the clinical characteristics of 7 COVID-19 patients diagnosed in our hospital, as well as the results of precise individual intervention treatment with TCM-WM, including laboratory examination, and CT changes of imaging. Results: On admission, laboratory results showed that 7 patients' overall Lymphocyte count (LYM#), Percent Lymphocytes (LYM %), and Alanine aminotransferase (ALT) were reduced, but Neutrophil percentage (NEU%) were increased. CT imaging showed that most patients had multiple patchy shadows and ground-glass shadows in both lungs. After TCM-WM treatment, the above pathological states were significantly improved. All patients were followed up and had a good prognosis. Conclusions: Accurate therapy with TCM-WM can quickly and effectively alleviate and treat patients with COVID-19, without severe Long Covid
Recommended from our members
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease
Background: PDLIM2 is essential for the termination of the inflammatory transcription factors NF-κB and STAT but is dispensable for the development of immune cells and immune tissues/organs. Currently, it remains unknown whether and how PDLIM2 is involved in physiologic and pathogenic processes. Results: Here we report that naive PDLIM2 deficient CD4+ T cells were prone to differentiate into Th1 and Th17 cells. PDLIM2 deficiency, however, had no obvious effect on lineage commitment towards Th2 or Treg cells. Notably, PDLIM2 deficient mice exhibited increased susceptibility to experimental autoimmune encephalitis (EAE), a Th1 and/or Th17 cell-mediated inflammatory disease model of multiple sclerosis (MS). Mechanistic studies further indicate that PDLIM2 was required for restricting expression of Th1 and Th17 cytokines, which was in accordance with the role of PDLIM2 in the termination of NF-κB and STAT activation. Conclusion: These findings suggest that PDLIM2 is a key modulator of T-cell-mediated immune responses that may be targeted for the therapy of human autoimmune diseases
HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome
BackgroundColposcopy is recommended once human papillomavirus (HPV)16/18 infection is detected. However, not all HPV16/18-positive women will necessarily develop cervical lesions. Therefore, this study aimed to investigate the application of quantitative HPV16 E7 oncoprotein detection as a cervical cancer screening method for more efficient screening while minimizing unnecessary colposcopy.MethodsE7 oncoprotein (HPV16) was quantitatively detected in cervical exfoliated cells of HPV16-positive women. The levels of HPV16 E7 oncoprotein in different degrees of cervical lesions were compared, and the optimal cut-off value for identifying HSIL+ was determined by receiver operating characteristic (ROC) curve analysis. With a pathological diagnosis as the gold standard, the sensitivity (SEN), specificity (SPE), positive predictive value (PPV), negative predictive value (NPV), and Kappa value were calculated to verify the diagnostic value of the method. Women diagnosed with low-grade squamous intraepithelial lesions (LSIL) and normal women were followed up for 5 years to evaluate the predictive value of HPV16 E7 protein for disease progression/persistent infection.ResultsThe expression level of HPV16 E7 oncoprotein was positively correlated with the degree of the cervical lesion (r = 0.589, P < 0.01). The area under the ROC curve (AUC) was 0.817 (confidence interval: 0.729–0.904). The cut-off value of E7 oncoprotein for identifying HSIL+ was 8.68 ng/ml. The SEN, SPE, PPV, NPV, and Kappa values of HPV16 E7 oncoprotein for the identification of HSIL+ were 87.1%,70.0%, 87.1%, 70.0%, and 0.571, respectively, which were higher than those of ThinPrep cytology test (TCT). The SEN, SPE, PPV, and NPV of HPV16 E7 oncoprotein in predicting disease progression/persistent infection were 93.75%, 91.30%, 88.24%, and 95.45%, respectively.ConclusionThe quantitative detection of HPV 16 E7 oncoprotein can not only accurately screen cervical lesions but also achieve efficient colposcopy referral. Additionally, HPV16 E7 oncoprotein can accurately predict the progression of cervical lesions and persistent HPV infection
Liver-Targeted Combination Therapy Basing on Glycyrrhizic Acid-Modified DSPE-PEG-PEI Nanoparticles for Co-delivery of Doxorubicin and Bcl-2 siRNA
Combination therapy based on nano-sized drug delivery system has been developed as a promising strategy by combining two or more anti-tumor mechanisms. Here, we prepared liver-targeted nanoparticles (GH-DPP) composed of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-polyetherimide (DSPE-PEG-PEI) with Glycyrrhetinic acid-modified hyaluronic acid (GA-HA) for co-delivery of doxorubicin (DOX) and Bcl-2 siRNA. Particles size, zeta potential and morphology were determined for the drug-loaded GH-DPP nanoparticles (siRNA/DOX/GH-DPP). Cellular uptake and in vitro cytotoxicity were analyzed against HepG2 cells. In vivo bio-distribution and anti-tumor therapeutic effects of siRNA/DOX/GH-DPP were evaluated in H22-bearing mice. The results showed that siRNA/DOX/GH-DPP nanoparticles were nearly spherical and showed dose-dependent cytotoxicity against HepG2 cells. Compared to Glycyrrhetinic acid-free co-delivery system (siRNA/DOX/DPP) and GH-DPP nanoparticles for delivery of DOX or Bcl-2 siRNA alone, siRNA/DOX/GH-DPP nanoparticles could induce more cellular apoptosis, and showed higher anti-tumor effect. Herein GH-DPP nanoparticles could simultaneously deliver both chemotherapy drugs and siRNA into the tumor region, exhibiting great potential in anti-tumor therapy
CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents
Multidrug resistance (MDR) of hepatocellular carcinoma is a serious problem. Although CD13 is a biomarker in human liver cancer stem cells, the relationship between CD13 and MDR remains uncertain. This study uses liver cancer cell model to understand the role of CD13 in enhancing the cytotoxic effect of chemotherapy agents. Cytotoxic agents can induce CD13 expression. CD13 inhibitor, bestatin, enhances the antitumor effect of cytotoxic agents. Meanwhile, CD13-targeting siRNA and neutralizing antibody can enhance the cytotoxic effect of 5-fluorouracil (5FU). CD13 overexpression increases cell survival upon cytotoxic agents treatment, while the knockdown of CD13 causes hypersensitivity of cells to cytotoxic agents treatment. Mechanistically, the inhibition of CD13 leads to the increase of cellular reactive oxygen species (ROS). BC-02 is a novel mutual prodrug (hybrid drug) of bestatin and 5FU. Notably, BC-02 can inhibit cellular activity in both parental and drug-resistant cells, accompanied with significantly increased ROS level. Moreover, the survival time of Kunming mice bearing H22 cells under BC-02 treatment is comparable to the capecitabine treatment at maximum dosage. These data implicate a therapeutic method to reverse MDR by targeting CD13, and indicate that BC-02 is a potent antitumor compound
Nuclear Morphological Remodeling in Human Granulocytes Is Linked to Prenylation Independently from Cytoskeleton
Nuclear shape modulates cell behavior and function, while aberrant nuclear morphologies
correlate with pathological phenotype severity. Nevertheless, functions of specific nuclear morphological
features and underlying molecular mechanisms remain poorly understood. Here, we investigate a
nucleus-intrinsic mechanism driving nuclear lobulation and segmentation concurrent with granulocyte
specification, independently from extracellular forces and cytosolic cytoskeleton contributions.
Transcriptomic regulation of cholesterol biosynthesis is equally concurrent with nuclear remodeling.
Its putative role as a regulatory element is supported by morphological aberrations observed upon
pharmacological impairment of several enzymatic steps of the pathway, most prominently the sterol
D14-reductase activity of laminB-receptor and protein prenylation. Thus, we support the hypothesis
of a nuclear-intrinsic mechanism for nuclear shape control with the putative involvement of the
recently discovered GGTase III complex. Such process could be independent from or complementary
to the better studied cytoskeleton-based nuclear remodeling essential for cell migration in both
physiological and pathological contexts such as immune system function and cancer metastasis
Yttrium doped TiO2 porous film photoanode for dye-sensitized solar cells with enhanced photovoltaic performance
In this paper, TiO2 photoanodes were doped with yttrium under different doping concentrations via hydrothermal method and further employed to assemble dye-sensitized solar cells (DSSCs). XRD, XPS, SEM, TEM, UV–Vis DRS and PL measurements were carried out to investigate the yttrium doping effects on crystal structure, chemical status, optical properties and dye loading capacity of the photoanodes. The photovoltaic performance of the photoanodes with various yttrium doping concentration was measured by recording the photocurrent-photovoltaic curves, and the result indicated that TiO2:0.006 Y exhibited the best power conversion efficiency with high short circuit current density (Jsc) and open circuit voltage (Voc). This improvement may be due to the enhanced visible light harvesting, increased dye loading capacity and reduced photoelectron recombination. Keywords: Dye sensitized solar cells, TiO2 photoanode, Rare earth doping, Yttriu
- …